Byvalson Side Effects
Generic name: nebivolol / valsartan
Medically reviewed by Drugs.com. Last updated on Aug 16, 2022.
Note: This document contains side effect information about nebivolol / valsartan. Some dosage forms listed on this page may not apply to the brand name Byvalson.
More frequent side effects include: increased serum potassium. Continue reading for a comprehensive list of adverse effects.
Oral route (Tablet)
When pregnancy is detected, discontinue nebivolol / valsartan as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
Serious side effects of Byvalson
Along with its needed effects, nebivolol / valsartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking nebivolol / valsartan:
Incidence not known
- Abdominal or stomach pain
- blurred vision
- chest pain
- decreased urine output
- difficult breathing
- dilated neck veins
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- extreme fatigue
- irregular breathing
- irregular heartbeat
- nausea or vomiting
- numbness or tingling in the hands, feet, or lips
- swelling of the face, fingers, feet, or lower legs
- tightness in the chest
- troubled breathing
- unusual tiredness or weakness
- weakness or heaviness of the legs
- weight gain
For Healthcare Professionals
Applies to nebivolol / valsartan: oral tablet.
Frequency not reported: Hypotension
Postmarketing reports: Atrioventricular block (both second and third degree), myocardial infarction, Raynaud's phenomenon, peripheral ischemia/claudication
Rare (0.01% to 0.1%): Angioedema
Postmarketing reports: Vomiting[Ref]
Postmarketing reports: Erectile dysfunction
Postmarketing reports: Thrombocytopenia
Postmarketing reports: Thrombocytopenia[Ref]
Postmarketing reports: Abnormal hepatic function (including increased AST, ALT, and bilirubin)
Postmarketing reports: Elevated liver enzymes, hepatitis
Postmarketing reports: Angioedema[Ref]
Common (1% to 10%): Hyperkalemia
Postmarketing reports: Hyperkalemia[Ref]
Postmarketing reports: Acute renal failure
Postmarketing reports: Impaired renal function, renal failure[Ref]
Frequently asked questions
More about Byvalson (nebivolol / valsartan)
- Check interactions
- Imprints, shape & color data
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antihypertensive combinations
- En español
Related treatment guides
1. "Product Information. Byvalson (nebivolol-valsartan)." Actavis Pharma, Inc. (2016):
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.